<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom"><generator uri="https://jekyllrb.com/" version="4.4.1">Jekyll</generator><link href="https://ipekselcen.github.io/feed.xml" rel="self" type="application/atom+xml"/><link href="https://ipekselcen.github.io/" rel="alternate" type="text/html"/><updated>2026-01-10T17:08:29+00:00</updated><id>https://ipekselcen.github.io/feed.xml</id><title type="html">blank</title><subtitle>Recent PhD graduate in Biochemistry specializing in epigenetics, chromatin biology, and multi-omics analysis. Bridging wet lab expertise with computational approaches. </subtitle><entry><title type="html">Beyond the Textbook: How TET1 Discovery Reveals Computational Thinking in Biology</title><link href="https://ipekselcen.github.io/blog/2026/tet1-computational-thinking/" rel="alternate" type="text/html" title="Beyond the Textbook: How TET1 Discovery Reveals Computational Thinking in Biology"/><published>2026-01-02T00:00:00+00:00</published><updated>2026-01-02T00:00:00+00:00</updated><id>https://ipekselcen.github.io/blog/2026/tet1-computational-thinking</id><content type="html" xml:base="https://ipekselcen.github.io/blog/2026/tet1-computational-thinking/"><![CDATA[<p>When TET1 was discovered in 2009, the biology community celebrated a biochemical breakthrough: an enzyme that oxidizes 5-methylcytosine. Science and Cell papers flooded in. Textbooks got updated. Case closed, right?</p> <p>But here’s what most people missed: TET1’s discovery didn’t just reveal a new enzyme. It revealed that DNA methylation is a <strong>computational system</strong> with states, transitions, and information processing capabilities that traditional biochemistry couldn’t predict.</p> <p>If you learn to think about TET1 computationally, you’ll understand not just what it does, but how to predict what happens when you perturb it. You’ll stop memorizing pathways and start understanding biological systems as algorithms running on molecular hardware.</p> <h2 id="part-1-the-story-your-textbook-told-you">Part 1: The Story Your Textbook Told You</h2> <p>For decades, DNA methylation seemed simple:</p> <blockquote class="block-warning"> <p><strong>The Old Model:</strong></p> <p>CpG islands + DNMT enzymes → 5-methylcytosine (5mC)<br/> 5mC = Gene Silencing = Heterochromatin = “Off”</p> <p>Unmethylated = Gene Active = Euchromatin = “On”</p> </blockquote> <p>It was binary. Clean. Wrong.</p> <p>The problem? Nobody could explain <strong>active demethylation</strong>. Sure, DNA methylation patterns could be diluted through cell division (passive demethylation), but what about when cells needed to rapidly activate a silenced gene?</p> <p>The prevailing assumption was “it probably just doesn’t happen much” or “maybe some repair pathway does it accidentally.”</p> <blockquote class="block-tip"> <p><strong>Computational Insight</strong></p> <p>Binary switches are <strong>informationally poor</strong>. Real biological systems encode information in richer state spaces. Computational thinkers should have been suspicious.</p> </blockquote> <h2 id="part-2-the-plot-twist---tet1-reveals-a-state-space">Part 2: The Plot Twist - TET1 Reveals a State Space</h2> <p>In 2009, Anjana Rao’s lab discovered TET1 doesn’t remove methylation directly. Instead:<sup>1</sup></p> <div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>5mC --TET1--&gt; 5hmC --TET1--&gt; 5fC --TET1--&gt; 5caC --TDG/BER--&gt; C
</code></pre></div></div> <p>This wasn’t just a pathway. It was a <strong>revelation about information encoding</strong>.</p> <h3 id="why-this-matters-computationally">Why This Matters Computationally</h3> <p>Instead of a binary switch, DNA now has at least <strong>five distinct states</strong> at every cytosine:</p> <ol> <li><strong>C</strong> (cytosine) - unmethylated</li> <li><strong>5mC</strong> (5-methylcytosine) - methylated</li> <li><strong>5hmC</strong> (5-hydroxymethylcytosine) - oxidized once</li> <li><strong>5fC</strong> (5-formylcytosine) - oxidized twice</li> <li><strong>5caC</strong> (5-carboxylcytosine) - oxidized thrice</li> </ol> <p>Each state has different:</p> <ul> <li><strong>Protein binding partners</strong> (readers that recognize different marks)</li> <li><strong>Chemical stability</strong> (transition rates between states)</li> <li><strong>Biological functions</strong> (gene activation vs. silencing vs. poising)</li> </ul> <p>This is exactly how computer scientists think about state machines. DNA methylation isn’t a bit (0 or 1), it’s more like a <strong>multi-level cell in flash memory</strong> that can store graded information.</p> <blockquote class="block-tip"> <p><strong>Key Insight</strong></p> <p>By revealing oxidized methylcytosines, TET1 showed that the genome has <strong>2.3x more information encoding capacity</strong> than we thought.</p> <p>This is profound. It means:</p> <ul> <li>More nuanced gene regulation is possible</li> <li>Cell identity can be encoded more stably</li> <li>Developmental transitions can be more precisely controlled</li> </ul> </blockquote> <h2 id="part-3-computational-reframing---from-biochemistry-to-information-theory">Part 3: Computational Reframing - From Biochemistry to Information Theory</h2> <p>Let’s formalize this. Here’s how a computational biologist thinks about the TET1 discovery:</p> <div class="language-python highlighter-rouge"><div class="highlight"><pre class="highlight"><code><span class="c1"># Traditional thinking (binary)
</span><span class="k">class</span> <span class="nc">DNAMethylation_Old</span><span class="p">:</span>
    <span class="k">def</span> <span class="nf">__init__</span><span class="p">(</span><span class="n">self</span><span class="p">):</span>
        <span class="n">self</span><span class="p">.</span><span class="n">state</span> <span class="o">=</span> <span class="sh">"</span><span class="s">unmethylated</span><span class="sh">"</span>  <span class="c1"># or "methylated"
</span>    
    <span class="k">def</span> <span class="nf">set_methylation</span><span class="p">(</span><span class="n">self</span><span class="p">,</span> <span class="n">methylated</span><span class="p">):</span>
        <span class="n">self</span><span class="p">.</span><span class="n">state</span> <span class="o">=</span> <span class="sh">"</span><span class="s">methylated</span><span class="sh">"</span> <span class="k">if</span> <span class="n">methylated</span> <span class="k">else</span> <span class="sh">"</span><span class="s">unmethylated</span><span class="sh">"</span>

<span class="c1"># Computational thinking (state space)
</span><span class="k">class</span> <span class="nc">DNAMethylation_New</span><span class="p">:</span>
    <span class="k">def</span> <span class="nf">__init__</span><span class="p">(</span><span class="n">self</span><span class="p">):</span>
        <span class="n">self</span><span class="p">.</span><span class="n">states</span> <span class="o">=</span> <span class="p">{</span>
            <span class="sh">'</span><span class="s">C</span><span class="sh">'</span><span class="p">:</span> <span class="p">{</span>
                <span class="sh">'</span><span class="s">energy</span><span class="sh">'</span><span class="p">:</span> <span class="mf">0.0</span><span class="p">,</span>
                <span class="sh">'</span><span class="s">stability</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">high</span><span class="sh">'</span><span class="p">,</span>
                <span class="sh">'</span><span class="s">transitions</span><span class="sh">'</span><span class="p">:</span> <span class="p">{</span><span class="sh">'</span><span class="s">5mC</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">DNMT</span><span class="sh">'</span><span class="p">},</span>
                <span class="sh">'</span><span class="s">readers</span><span class="sh">'</span><span class="p">:</span> <span class="p">[</span><span class="sh">'</span><span class="s">CXXC</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">TET</span><span class="sh">'</span><span class="p">]</span>
            <span class="p">},</span>
            <span class="sh">'</span><span class="s">5mC</span><span class="sh">'</span><span class="p">:</span> <span class="p">{</span>
                <span class="sh">'</span><span class="s">energy</span><span class="sh">'</span><span class="p">:</span> <span class="o">-</span><span class="mf">2.0</span><span class="p">,</span>  <span class="c1"># thermodynamically stable
</span>                <span class="sh">'</span><span class="s">stability</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">high</span><span class="sh">'</span><span class="p">,</span>
                <span class="sh">'</span><span class="s">transitions</span><span class="sh">'</span><span class="p">:</span> <span class="p">{</span><span class="sh">'</span><span class="s">5hmC</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">TET</span><span class="sh">'</span><span class="p">},</span>
                <span class="sh">'</span><span class="s">readers</span><span class="sh">'</span><span class="p">:</span> <span class="p">[</span><span class="sh">'</span><span class="s">MBD</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">MeCP2</span><span class="sh">'</span><span class="p">]</span>
            <span class="p">},</span>
            <span class="sh">'</span><span class="s">5hmC</span><span class="sh">'</span><span class="p">:</span> <span class="p">{</span>
                <span class="sh">'</span><span class="s">energy</span><span class="sh">'</span><span class="p">:</span> <span class="o">-</span><span class="mf">1.0</span><span class="p">,</span>  <span class="c1"># intermediate stability
</span>                <span class="sh">'</span><span class="s">stability</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">medium</span><span class="sh">'</span><span class="p">,</span>
                <span class="sh">'</span><span class="s">transitions</span><span class="sh">'</span><span class="p">:</span> <span class="p">{</span><span class="sh">'</span><span class="s">5fC</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">TET</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">5mC</span><span class="sh">'</span><span class="p">:</span> <span class="sh">'</span><span class="s">reverse?</span><span class="sh">'</span><span class="p">},</span>
                <span class="sh">'</span><span class="s">readers</span><span class="sh">'</span><span class="p">:</span> <span class="p">[</span><span class="sh">'</span><span class="s">Uhrf2</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">WT1</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">MeCP2</span><span class="sh">'</span><span class="p">]</span>
            <span class="p">},</span>
            <span class="c1"># ... and so on
</span>        <span class="p">}</span>
</code></pre></div></div> <h2 id="part-4-what-computational-thinking-lets-you-predict">Part 4: What Computational Thinking Lets You Predict</h2> <p>Now that we have a state space model, we can ask questions that pure biochemistry couldn’t answer:</p> <h3 id="question-1-is-5hmc-a-transient-intermediate-or-a-stable-mark">Question 1: Is 5hmC a Transient Intermediate or a Stable Mark?</h3> <p><strong>Traditional approach:</strong> Measure 5hmC levels in cells. If you find it, it exists. Done.</p> <p><strong>Computational approach:</strong> Model the kinetics and predict steady-state levels.</p> <div class="language-r highlighter-rouge"><div class="highlight"><pre class="highlight"><code><span class="c1"># Kinetic model</span><span class="w">
</span><span class="c1"># Let k1 = rate of 5mC → 5hmC conversion</span><span class="w">
</span><span class="c1"># Let k2 = rate of 5hmC → 5fC conversion</span><span class="w">

</span><span class="c1"># If 5hmC is just a transient intermediate:</span><span class="w">
</span><span class="c1"># k1 ≈ k2 (fast in, fast out)</span><span class="w">
</span><span class="c1"># Steady state: [5hmC] ≈ 0</span><span class="w">

</span><span class="c1"># If 5hmC is a stable regulatory mark:</span><span class="w">
</span><span class="c1"># k1 &gt; k2 (fast in, slow out)</span><span class="w">
</span><span class="c1"># Steady state: [5hmC] accumulates</span><span class="w">
</span></code></pre></div></div> <p><strong>What the data showed:</strong> Koh et al. (2011) found that in embryonic stem cells (ESCs), 5hmC is <strong>abundant</strong> - sometimes comprising 1% of all cytosines.<sup>3</sup></p> <p><strong>Computational conclusion:</strong> k₂ must be rate-limiting. This means <strong>5hmC is not just an intermediate</strong> - it’s a stable epigenetic mark with its own regulatory function.</p> <blockquote class="block-tip"> <p><strong>Biological Insight</strong></p> <p>Cells use 5hmC to poise genes - maintaining them in an intermediate state between “off” (5mC) and “on” (C). This is exactly what you’d want during development when cells need to maintain flexibility before committing to a fate.</p> </blockquote> <h3 id="question-2-network-redundancy---why-three-tet-enzymes">Question 2: Network Redundancy - Why Three TET Enzymes?</h3> <p>Mammals don’t just have TET1. They have TET1, TET2, and TET3.</p> <p><strong>Traditional thinking:</strong> “Probably just redundancy. Evolution is messy.”</p> <p><strong>Computational thinking:</strong> Redundancy in biological networks is rarely accidental. It’s either:</p> <ol> <li><strong>Fault tolerance</strong> (backup systems)</li> <li><strong>Specialization</strong> (different contexts)</li> <li><strong>Signal amplification</strong> (parallel processing)</li> </ol> <p>Let’s model this:</p> <div class="language-python highlighter-rouge"><div class="highlight"><pre class="highlight"><code><span class="kn">import</span> <span class="n">networkx</span> <span class="k">as</span> <span class="n">nx</span>

<span class="c1"># Build a simplified gene regulatory network
</span><span class="n">G</span> <span class="o">=</span> <span class="n">nx</span><span class="p">.</span><span class="nc">DiGraph</span><span class="p">()</span>

<span class="c1"># Add nodes
</span><span class="n">genes</span> <span class="o">=</span> <span class="p">[</span><span class="sh">'</span><span class="s">Gene_A</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">Gene_B</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">Gene_C</span><span class="sh">'</span><span class="p">]</span>
<span class="n">enzymes</span> <span class="o">=</span> <span class="p">[</span><span class="sh">'</span><span class="s">TET1</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">TET2</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">TET3</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">DNMT3A</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">DNMT3B</span><span class="sh">'</span><span class="p">]</span>

<span class="n">G</span><span class="p">.</span><span class="nf">add_nodes_from</span><span class="p">(</span><span class="n">genes</span><span class="p">,</span> <span class="n">node_type</span><span class="o">=</span><span class="sh">'</span><span class="s">gene</span><span class="sh">'</span><span class="p">)</span>
<span class="n">G</span><span class="p">.</span><span class="nf">add_nodes_from</span><span class="p">(</span><span class="n">enzymes</span><span class="p">,</span> <span class="n">node_type</span><span class="o">=</span><span class="sh">'</span><span class="s">enzyme</span><span class="sh">'</span><span class="p">)</span>

<span class="c1"># TET enzymes activate genes by oxidizing 5mC
</span><span class="k">for</span> <span class="n">tet</span> <span class="ow">in</span> <span class="p">[</span><span class="sh">'</span><span class="s">TET1</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">TET2</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">TET3</span><span class="sh">'</span><span class="p">]:</span>
    <span class="k">for</span> <span class="n">gene</span> <span class="ow">in</span> <span class="n">genes</span><span class="p">:</span>
        <span class="n">G</span><span class="p">.</span><span class="nf">add_edge</span><span class="p">(</span><span class="n">tet</span><span class="p">,</span> <span class="n">gene</span><span class="p">,</span> <span class="n">interaction</span><span class="o">=</span><span class="sh">'</span><span class="s">activate</span><span class="sh">'</span><span class="p">)</span>

<span class="c1"># Key computational question: What happens if we remove TET1?
</span><span class="n">G_knockout</span> <span class="o">=</span> <span class="n">G</span><span class="p">.</span><span class="nf">copy</span><span class="p">()</span>
<span class="n">G_knockout</span><span class="p">.</span><span class="nf">remove_node</span><span class="p">(</span><span class="sh">'</span><span class="s">TET1</span><span class="sh">'</span><span class="p">)</span>

<span class="c1"># Can genes still be activated?
</span><span class="k">for</span> <span class="n">gene</span> <span class="ow">in</span> <span class="n">genes</span><span class="p">:</span>
    <span class="n">alternative_activators</span> <span class="o">=</span> <span class="p">[</span><span class="n">node</span> <span class="k">for</span> <span class="n">node</span> <span class="ow">in</span> <span class="p">[</span><span class="sh">'</span><span class="s">TET2</span><span class="sh">'</span><span class="p">,</span> <span class="sh">'</span><span class="s">TET3</span><span class="sh">'</span><span class="p">]</span> 
                              <span class="k">if</span> <span class="n">nx</span><span class="p">.</span><span class="nf">has_path</span><span class="p">(</span><span class="n">G_knockout</span><span class="p">,</span> <span class="n">node</span><span class="p">,</span> <span class="n">gene</span><span class="p">)]</span>
    <span class="nf">print</span><span class="p">(</span><span class="sa">f</span><span class="sh">"</span><span class="si">{</span><span class="n">gene</span><span class="si">}</span><span class="s"> can still be activated by: </span><span class="si">{</span><span class="n">alternative_activators</span><span class="si">}</span><span class="sh">"</span><span class="p">)</span>
</code></pre></div></div> <p><strong>Output:</strong></p> <div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>Gene_A can still be activated by: ['TET2', 'TET3']
Gene_B can still be activated by: ['TET2', 'TET3']
Gene_C can still be activated by: ['TET2', 'TET3']
</code></pre></div></div> <p><strong>Computational prediction:</strong> TET1 knockout should show <strong>partial compensation</strong> by TET2/3, not complete loss of function.</p> <p><strong>Experimental validation:</strong> Dawlaty et al. (2011) showed that TET1 knockout mice are viable and fertile, with only subtle defects. TET2 and TET3 expression increases to compensate.<sup>4</sup></p> <p>This is network robustness in action - exactly what graph theory predicts for scale-free biological networks.</p> <blockquote class="block-warning"> <p><strong>Note</strong></p> <p>My unpublished TET2 work revealed even more sophisticated compensation mechanisms that traditional thinking wouldn’t predict. More on that after publication.</p> </blockquote> <h2 id="part-5-multi-omics-integration---the-computational-payoff">Part 5: Multi-Omics Integration - The Computational Payoff</h2> <p>Here’s where computational thinking really shines. Once you understand the state space and network properties, you can integrate multiple data types to test mechanistic hypotheses.</p> <h3 id="the-computational-framework">The Computational Framework</h3> <div class="language-r highlighter-rouge"><div class="highlight"><pre class="highlight"><code><span class="c1"># Integrating multiple genomics datasets to understand TET1 function</span><span class="w">
</span><span class="n">library</span><span class="p">(</span><span class="n">tidyverse</span><span class="p">)</span><span class="w">
</span><span class="n">library</span><span class="p">(</span><span class="n">GenomicRanges</span><span class="p">)</span><span class="w">

</span><span class="c1"># Step 1: Define the computational question</span><span class="w">
</span><span class="c1"># "Does 5hmC presence causally regulate gene expression?"</span><span class="w">
</span><span class="c1"># Or: "Is 5hmC a marker of regulatory potential?"</span><span class="w">

</span><span class="c1"># Step 2: Formalize as a statistical model</span><span class="w">
</span><span class="c1"># H1 (causal): Expression = f(5hmC_level)</span><span class="w">
</span><span class="c1"># H2 (marker): Expression = f(chromatin_state), 5hmC correlates with both</span><span class="w">

</span><span class="c1"># Step 3: Model the relationships</span><span class="w">
</span><span class="n">model1</span><span class="w"> </span><span class="o">&lt;-</span><span class="w"> </span><span class="n">lm</span><span class="p">(</span><span class="n">expression</span><span class="w"> </span><span class="o">~</span><span class="w"> </span><span class="n">hmC_in_promoter</span><span class="p">,</span><span class="w"> </span><span class="n">data</span><span class="w"> </span><span class="o">=</span><span class="w"> </span><span class="n">integrated_data</span><span class="p">)</span><span class="w">
</span><span class="n">model2</span><span class="w"> </span><span class="o">&lt;-</span><span class="w"> </span><span class="n">lm</span><span class="p">(</span><span class="n">expression</span><span class="w"> </span><span class="o">~</span><span class="w"> </span><span class="n">chromatin_open</span><span class="p">,</span><span class="w"> </span><span class="n">data</span><span class="w"> </span><span class="o">=</span><span class="w"> </span><span class="n">integrated_data</span><span class="p">)</span><span class="w">
</span><span class="n">model3</span><span class="w"> </span><span class="o">&lt;-</span><span class="w"> </span><span class="n">lm</span><span class="p">(</span><span class="n">expression</span><span class="w"> </span><span class="o">~</span><span class="w"> </span><span class="n">hmC_in_promoter</span><span class="w"> </span><span class="o">+</span><span class="w"> </span><span class="n">chromatin_open</span><span class="w"> </span><span class="o">+</span><span class="w"> 
                         </span><span class="n">hmC_in_promoter</span><span class="o">:</span><span class="n">chromatin_open</span><span class="p">,</span><span class="w"> 
             </span><span class="n">data</span><span class="w"> </span><span class="o">=</span><span class="w"> </span><span class="n">integrated_data</span><span class="p">)</span><span class="w">

</span><span class="c1"># The interaction term tests: Does 5hmC's effect depend on chromatin state?</span><span class="w">
</span><span class="c1"># If interaction is significant → context-dependent regulation</span><span class="w">
</span></code></pre></div></div> <h3 id="what-this-reveals">What This Reveals</h3> <p>Published TET1 multi-omics studies (Wu et al., 2011; Huang et al., 2014) showed:<sup>5,6</sup></p> <ol> <li><strong>5hmC enrichment at enhancers and gene bodies</strong> correlates with <strong>active transcription</strong></li> <li><strong>TET1 binding</strong> overlaps with <strong>H3K4me3</strong> (active promoter mark) and <strong>open chromatin</strong></li> <li><strong>TET1 knockout</strong> causes modest gene expression changes (hundreds, not thousands of genes)</li> </ol> <blockquote class="block-tip"> <p><strong>Computational Interpretation</strong></p> <p>5hmC is not a simple activator. It’s a component of a regulatory PROGRAM.</p> <p>The cell isn’t asking: “Is there 5hmC here?”<br/> The cell is computing:</p> <div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>IF (5hmC present) AND (chromatin accessible) AND (TFs bound)
THEN (transcription permissible)
</code></pre></div> </div> <p>This is a logical AND gate, not a simple input-output function.</p> </blockquote> <p>This is why <strong>context matters</strong> in epigenetics. 5hmC at a closed chromatin region does nothing. 5hmC at an open, TF-bound enhancer facilitates activation.</p> <p>The computational mindset lets you see that epigenetic marks are <strong>boolean variables in a complex logical circuit</strong>, not simple on/off switches.</p> <h2 id="part-6-the-unthinkable-that-emerges-from-computational-thinking">Part 6: The “Unthinkable” That Emerges From Computational Thinking</h2> <p>Let me summarize what TET1 teaches us when we think computationally:</p> <h3 id="1-state-space-complexity--regulatory-flexibility">1. State Space Complexity = Regulatory Flexibility</h3> <p><strong>Biochemistry tells you:</strong> TET1 oxidizes 5mC<br/> <strong>Computation tells you:</strong> This creates a 5-state system with 2.3x more information capacity</p> <p><strong>Why it matters:</strong> Cells can encode “poised,” “active,” “repressed,” “irreversible” states, not just “on/off”</p> <h3 id="2-network-redundancy--robust-computation">2. Network Redundancy = Robust Computation</h3> <p><strong>Biochemistry tells you:</strong> Three TET enzymes exist<br/> <strong>Computation tells you:</strong> This creates fault-tolerant parallel processing with graceful degradation</p> <p><strong>Why it matters:</strong> Perturbations (mutations, knockouts, drugs) won’t simply break the system - it will adapt</p> <h3 id="3-multi-layer-regulation--combinatorial-logic">3. Multi-Layer Regulation = Combinatorial Logic</h3> <p><strong>Biochemistry tells you:</strong> 5hmC correlates with gene activation<br/> <strong>Computation tells you:</strong> 5hmC is one input in a multi-input logic gate</p> <p><strong>Why it matters:</strong> You can’t predict gene expression from 5hmC alone - you need the full regulatory context</p> <h3 id="4-information-flow-reveals-causality">4. Information Flow Reveals Causality</h3> <p><strong>Biochemistry tells you:</strong> TET1 binds here, 5hmC appears here, gene expression changes<br/> <strong>Computation tells you:</strong> Correlation ≠ causation until you model the directed acyclic graph</p> <p><strong>Why it matters:</strong> You can now design perturbation experiments that test causal links</p> <h2 id="part-7-how-to-practice-computational-thinking">Part 7: How to Practice Computational Thinking</h2> <p>Before you run your next ChIP-seq, RNA-seq, or ATAC-seq analysis, ask yourself these questions:</p> <h3 id="the-computational-thinking-checklist">The Computational Thinking Checklist</h3> <p><strong>□ 1. What is the state space of my system?</strong></p> <ul> <li>Not just “methylated vs unmethylated”</li> <li>What are ALL the possible states?</li> <li>What information do these states encode?</li> </ul> <p><strong>□ 2. What are the transition rules?</strong></p> <ul> <li>What enzymes/processes move between states?</li> <li>What are the rates? (fast/slow)</li> <li>Are transitions reversible?</li> </ul> <p><strong>□ 3. What is the network topology?</strong></p> <ul> <li>Who regulates whom?</li> <li>Are there feedback loops?</li> <li>Where is redundancy?</li> </ul> <p><strong>□ 4. What are the constraints?</strong></p> <ul> <li>Thermodynamic (energetics)</li> <li>Topological (chromatin structure)</li> <li>Temporal (developmental time)</li> <li>Spatial (nuclear organization)</li> </ul> <p><strong>□ 5. What does this topology predict about perturbations?</strong></p> <ul> <li>Single gene knockout = ?</li> <li>Drug treatment = ?</li> <li>Stress response = ?</li> </ul> <p><strong>□ 6. How do I integrate multiple measurements?</strong></p> <ul> <li>Are they measuring the same thing at different scales?</li> <li>Are they inputs and outputs of the same process?</li> <li>What’s the causal structure?</li> </ul> <p><strong>□ 7. What would surprise me?</strong></p> <ul> <li>If X happened, what would that tell me about my model?</li> <li>What result would force me to rethink my assumptions?</li> </ul> <h3 id="example-applying-this-to-your-next-experiment">Example: Applying This to Your Next Experiment</h3> <p>Let’s say you’re studying a TET enzyme (maybe TET2…) in your favorite cell type.</p> <blockquote class="block-danger"> <p><strong>❌ Bad computational thinking:</strong></p> <p>“I’ll knock out TET2, do RNA-seq, and see what genes change. Then I’ll make a GO term enrichment plot and call it a day.”</p> </blockquote> <blockquote class="block-tip"> <p><strong>✓ Good computational thinking:</strong></p> <p>“TET2 operates in a network with TET1/3, DNMTs, and chromatin remodelers. Before I even do the experiment, let me predict:</p> <ol> <li><strong>State space:</strong> What regulatory states exist in my cell type?</li> <li><strong>Network:</strong> Can TET1/3 compensate for TET2 loss?</li> <li><strong>Constraints:</strong> Is TET2 the rate-limiting enzyme, or is something downstream (TDG, BER)?</li> <li><strong>Time scale:</strong> How long until compensation mechanisms kick in?</li> </ol> <p>Based on these predictions, I should:</p> <ul> <li>Measure TET1/3 expression after TET2 KO (test compensation)</li> <li>Time-course RNA-seq (capture dynamics, not just endpoint)</li> <li>Multi-omics (5hmC, chromatin, expression) to see information flow</li> <li>Model the gene regulatory network before and after perturbation</li> </ul> <p>This way, I’m not just generating data. I’m testing a computational hypothesis about how the system works.”</p> </blockquote> <h2 id="whats-next">What’s Next</h2> <p>The TET1 story shows that computational thinking transforms how you understand biology. You stop seeing isolated biochemical reactions and start seeing:</p> <ul> <li><strong>State machines</strong> (methylation states)</li> <li><strong>Networks</strong> (gene regulation)</li> <li><strong>Information processing</strong> (epigenetic code)</li> <li><strong>Optimization</strong> (balancing stability vs flexibility)</li> <li><strong>Robustness</strong> (fault tolerance through redundancy)</li> </ul> <p>My own unpublished work on TET2 revealed even deeper layers of this computational architecture. When I knocked out TET2 in oligodendrocyte progenitor cells, the compensation mechanisms were far more sophisticated than simple TET1/3 upregulation. The cell rerouted information flow through RNA modification pathways, chromatin remodelers, and alternative demethylation routes - exactly the kind of network-level adaptation that computational thinking predicts.</p> <p>But that’s a story for after the paper is published.</p> <p>For now, I encourage you to practice this mindset with published systems. Pick your favorite epigenetic regulator and ask:</p> <ul> <li>What’s the state space?</li> <li>What’s the network?</li> <li>What would computation predict that biochemistry alone wouldn’t?</li> </ul> <blockquote class="block-tip"> <p><strong>Coming Up in This Series</strong></p> <p><strong>Next:</strong> “Chromatin as a Phase-Separated Material: Why Your ATAC-seq Peaks Aren’t What You Think”</p> <p><strong>Later:</strong> “The TET2 Compensation Network: A Case Study in Computational Prediction” (after publication)</p> <p><strong>Also:</strong> “Why Your Heatmap Is Lying To You: Dimensionality Reduction and Perceptual Biases”</p> </blockquote> <hr/> <h3 id="references">References</h3> <ol> <li>Tahiliani M, et al. (2009) “Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.” <em>Science</em> 324(5929):930-5.</li> <li>Kriaucionis S, Heintz N. (2009) “The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain.” <em>Science</em> 324(5929):929-30.</li> <li>Koh KP, et al. (2011) “Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.” <em>Cell Stem Cell</em> 8(2):200-13.</li> <li>Dawlaty MM, et al. (2011) “Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development.” <em>Cell Stem Cell</em> 9(2):166-75.</li> <li>Wu H, et al. (2011) “Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells.” <em>Genes Dev</em> 25(7):679-84.</li> <li>Huang Y, et al. (2014) “Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.” <em>PNAS</em> 111(4):1361-6.</li> <li>Alon U. (2007) “Network motifs: theory and experimental approaches.” <em>Nat Rev Genet</em> 8:450–461.</li> <li>Barabási AL, Oltvai ZN. (2004) “Network biology: understanding the cell’s functional organization.” <em>Nat Rev Genet</em> 5:101–113.</li> </ol>]]></content><author><name></name></author><category term="SciComm"/><category term="systems-biology"/><category term="computational-thinking"/><category term="epigenetics"/><category term="DNA-methylation"/><summary type="html"><![CDATA[Stop memorizing pathways. Start understanding biological systems as algorithms running on molecular hardware.]]></summary></entry><entry><title type="html">Tracking Glioblastoma’s Circular DNA at Single-Cell Resolution</title><link href="https://ipekselcen.github.io/blog/2025/glioblastoma-ecdna/" rel="alternate" type="text/html" title="Tracking Glioblastoma’s Circular DNA at Single-Cell Resolution"/><published>2025-10-30T00:00:00+00:00</published><updated>2025-10-30T00:00:00+00:00</updated><id>https://ipekselcen.github.io/blog/2025/glioblastoma-ecdna</id><content type="html" xml:base="https://ipekselcen.github.io/blog/2025/glioblastoma-ecdna/"><![CDATA[<p>Glioblastoma is the most lethal brain cancer we know, with a median survival under two years even with aggressive treatment. One reason it’s so hard to treat is extrachromosomal DNA, which are circular DNA molecules that carry amplified oncogenes and exist outside the normal chromosomes.</p> <h2 id="the-ecdna-problem">The ecDNA Problem</h2> <p>Extrachromosomal DNA, or ecDNA, shows up in about 50-60% of glioblastomas, making it one of the most ecDNA-rich cancers. These circular DNA molecules typically carry oncogenes such as EGFR, PDGFRA, and CDK4, which are all drivers of aggressive tumor growth. What makes ecDNA particularly dangerous is how it behaves during cell division. Unlike chromosomal DNA, which gets precisely copied and distributed to daughter cells, ecDNA segregates randomly. One daughter cell might inherit many copies while another gets few or none, creating massive cell-to-cell variation in oncogene dosage. This heterogeneity fuels drug resistance and tumor evolution.</p> <p>The problem is that most ecDNA studies have relied on bulk sequencing or imaging approaches that average across thousands of cells, missing this critical heterogeneity. We’ve needed a way to track ecDNA at single-cell resolution in patient samples.</p> <h2 id="what-they-did">What They Did</h2> <p>A team from Soochow University developed scCirclehunter, a computational framework specifically designed to identify ecDNA from single-cell ATAC-seq data. The clever part is how they exploit chromatin accessibility patterns. EcDNA regions show distinctive accessibility signatures because they exist as circles rather than being packed into chromatin like chromosomal DNA. The method uses a pseudo-bulk strategy to first identify candidate ecDNA regions across all cells, then assigns these ecDNAs to specific cell populations using statistical modeling.</p> <p>They applied scCirclehunter to existing glioblastoma scATAC-seq datasets and showed it could reliably detect ecDNA and determine which individual cells carry it. This matters because it finally lets you ask: which tumor cells have ecDNA? How many copies? And what are those cells doing differently?</p> <h2 id="key-findings">Key Findings</h2> <p>The analysis revealed striking inter-patient and intra-tumor heterogeneity. Across different glioblastoma patients, ecDNA-carrying cells showed distinct distributions. Some patients had ecDNA throughout most of their tumor, while others showed more patchy distributions. Within a single patient harboring multiple different ecDNAs, they could track separate malignant cell trajectories associated with each ecDNA species. Focusing on ecNR2E1 (an ecDNA carrying the NR2E1 oncogene), they integrated the chromatin accessibility data with matched single-cell RNA-seq to understand how ecDNA affects cellular behavior. The ecDNA didn’t just amplify NR2E1 expression—it drove broader transcriptional programs associated with tumor aggressiveness. Cells carrying ecNR2E1 showed activation of pathways involved in cell proliferation, survival, and immune evasion. An unexpected finding emerged around mitochondrial dynamics. Cells with ecDNA showed evidence of increased mitochondrial transfer, which is a process where cells exchange mitochondria with neighbors. This suggests ecDNA-carrying cells might be manipulating their local environment in ways beyond just overexpressing oncogenes.</p> <h2 id="why-this-matters">Why This Matters</h2> <p>This work provides a generalizable approach for studying ecDNA heterogeneity in any cancer where scATAC-seq data exists. The single-cell resolution matters clinically because it reveals that ecDNA distribution isn’t uniform: some regions of a tumor might be ecDNA-heavy while others aren’t. This has implications for biopsy sampling, where a single needle biopsy might miss or oversample ecDNA-positive regions, and for understanding why tumors respond heterogeneously to treatment.</p> <p>From a therapeutic standpoint, knowing which cells carry ecDNA and what those cells are doing opens new targeting strategies. Rather than just going after the oncogene itself (such as EGFR inhibitors that often fail in ecDNA-positive tumors), you could potentially target the unique vulnerabilities of ecDNA-carrying cells or the mechanisms that maintain ecDNA.</p> <blockquote class="block-warning"> <h5 id="warning">WARNING</h5> <p>The broader point is methodological: chromatin accessibility data, which many researchers are already generating, contains information about structural genomic alterations like ecDNA that we haven’t been systematically extracting. scCirclehunter provides a way to mine existing datasets for insights into tumor heterogeneity that would otherwise remain hidden.</p> </blockquote> <blockquote class="block-tip"> <h5 id="tip">TIP</h5> <p><strong>Bottom Line:</strong> Glioblastoma’s circular DNA drives heterogeneity and treatment resistance, but we’ve lacked tools to track it cell-by-cell in patients. Single-cell chromatin accessibility provides a window into which cells carry ecDNA and how that shapes tumor behavior. As ecDNA-targeted therapies move toward the clinic, understanding its distribution at single-cell resolution will be critical for rational treatment design.</p> </blockquote> <table> <tbody> <tr> <td><strong>Paper:</strong> Jiang et al., <em>Cell Discovery</em> (2024)</td> <td><a href="https://www.nature.com/articles/s41421-025-00842-9">Read the paper →</a></td> </tr> </tbody> </table> <h3 id="references">References</h3> <ol> <li>Kim H, Nguyen NP, Turner K, et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat Genet. 2020;52:891-897.</li> <li>Bailey C, Pich O, Thol K, et al. Origins and impact of extrachromosomal DNA. Nature. 2024;635:193-200.</li> <li>Lange JT, Rose JC, Chen CY, et al. The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat Genet. 2022;54:1527-1533.</li> <li>Nathanson DA, Gini B, Mottahedeh J, et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. 2014;343:72-76.</li> </ol>]]></content><author><name></name></author><category term="research-highlights"/><category term="circular"/><category term="DNA"/><category term="glioblastoma"/><category term="single-cell"/><category term="chromatin"/><summary type="html"><![CDATA[How single-cell epigenomics reveals that Alzheimer's is fundamentally about regulatory collapse, not just protein aggregates]]></summary></entry><entry><title type="html">Epigenomic Breakdown in Alzheimer’s: When Brain Cells Lose Control</title><link href="https://ipekselcen.github.io/blog/2025/alzheimers-epigenomics/" rel="alternate" type="text/html" title="Epigenomic Breakdown in Alzheimer’s: When Brain Cells Lose Control"/><published>2025-10-25T00:00:00+00:00</published><updated>2025-10-25T00:00:00+00:00</updated><id>https://ipekselcen.github.io/blog/2025/alzheimers-epigenomics</id><content type="html" xml:base="https://ipekselcen.github.io/blog/2025/alzheimers-epigenomics/"><![CDATA[<p>Most people think of Alzheimer’s disease in terms of plaques and tangles; the protein clumps that show up in brain scans. But a massive new study published in <em>Cell</em> this September reveals that the real story might be about something more fundamental: brain cells losing their grip on gene regulation itself.</p> <p>We’ve known for a while that Alzheimer’s doesn’t hit all brain regions equally. The hippocampus and entorhinal cortex (your memory centers) get hit early and hard, while other regions like the prefrontal cortex show damage later. But why? And at a cellular level, what’s actually breaking down?</p> <p>This is where single-cell epigenomics comes in. The epigenome (the chemical modifications that control which genes are accessible and which stay locked away) is essentially the instruction manual that tells each cell type how to be itself. When that manual gets corrupted, cells can’t maintain their identity or function properly. Single-cell technologies have revolutionized our ability to map cellular diversity and regulatory landscapes in the brain, but applying them to understand disease progression at this scale is still relatively new.</p> <h2 id="what-they-did">What They Did</h2> <p>The MIT and Broad Institute team, led by Manolis Kellis and Li-Huei Tsai, built the largest single-cell brain atlas for Alzheimer’s to date. They profiled 3.5 million individual cells from 384 postmortem brain samples spanning six different brain regions in 111 donors from the Religious Orders Study and Rush Memory and Aging Project (two well-characterized longitudinal cohort studies that have been instrumental in Alzheimer’s research).</p> <p>The donors ranged from people with no pathology to early-stage and late-stage disease. The key innovation is the integration of single-nucleus ATAC-seq (measuring chromatin accessibility) and single-nucleus RNA-seq (measuring gene expression) in the same tissue samples. This lets you see not just which genes are being expressed, but whether the regulatory machinery controlling those genes is intact or falling apart.</p> <h2 id="the-core-findings">The Core Findings</h2> <p>Two major patterns emerged that fundamentally change how we think about Alzheimer’s progression:</p> <p><strong>First: Epigenome relaxation and compartment breakdown.</strong> Healthy cells maintain strict spatial organization in their nuclei, with the genome partitioned into active and repressive compartments. Active compartments sit in the nuclear interior with accessible chromatin, while repressive compartments are near the nuclear periphery and lamina with higher A/T content.</p> <p>In Alzheimer’s, this organization breaks down. The cells experience what the authors call “epigenomic relaxation”: regions that should be tightly closed become accessible, and active regions lose their structure. Vulnerable neurons in the entorhinal cortex and hippocampus showed the most dramatic compartment switching, with normally repressive chromatin becoming inappropriately activated.</p> <p><strong>Second: Loss of epigenomic information.</strong> Each cell type has a unique epigenetic signature that defines what it is. In Alzheimer’s progression, cells lose this signature. They essentially forget how to be themselves. The study identified over 1 million candidate regulatory elements organized into 123 distinct modules across 67 cell subtypes, and tracked how these modules erode during disease.</p> <p>The loss was most pronounced in excitatory neurons in superficial cortical layers, somatostatin-positive inhibitory interneurons, oligodendrocytes, and microglia.</p> <p>Interestingly, glial cells showed a two-phase response. Early in disease, they gained epigenomic definition as they activated to respond to damage. But with sustained stress, they entered exhausted states and lost their epigenetic stability, especially pronounced in APOE4 carriers.</p> <h2 id="the-resilience-angle">The Resilience Angle</h2> <p>Here’s the hopeful part: some people maintained cognitive function despite having significant Alzheimer’s pathology in their brains. These “resilient” individuals showed something striking: their cells maintained higher epigenomic information across all brain regions compared to people who showed cognitive decline with similar pathology burdens. This suggests that preserving epigenetic stability might be protective, even when plaques and tangles are present.</p> <p>This study shifts the therapeutic conversation. Instead of just targeting plaques and tangles (the end products of disease) we could potentially target the regulatory factors that maintain epigenomic stability. The authors point to Polycomb complexes, which act as “epigenomic guardians” by maintaining chromatin structure. Strengthening these systems, or targeting the specific transcription factors that regulate vulnerable cell types, could offer new intervention strategies.</p> <p>The work complements a companion study published simultaneously in Cell, which found coordinated disruption of 3D genome organization alongside the epigenomic erosion described here. Together, these studies paint a comprehensive picture of how nuclear organization collapses in Alzheimer’s.</p> <p>The dataset itself is also a resource: all data is publicly available, giving the field a detailed molecular map of how different cell types in different brain regions respond to or resist Alzheimer’s pathology.</p> <h2 id="technical-notes">Technical Notes</h2> <p>The study used 10X Genomics platforms for both snATAC-seq (1.2 million nuclei) and snRNA-seq (2.3 million nuclei). They defined epigenomic compartments at genome-wide resolution using hidden Markov models, and calculated epigenomic information for single cells using Shannon entropy, quantifying how well cells maintain their cell-type-specific regulatory programs. Integration across regions and disease stages used Harmony for batch correction, with validation against ENCODE reference datasets.</p> <blockquote class="block-tip"> <h5 id="tip">TIP</h5> <p><strong>Bottom Line:</strong> Alzheimer’s isn’t just about protein aggregates. It’s about a progressive loss of the regulatory control that keeps brain cells functioning. Understanding epigenomic erosion opens new therapeutic avenues and helps explain why some people are resilient while others aren’t. This kind of comprehensive, multimodal atlas is exactly what the field needs to move beyond symptomatic treatments.</p> </blockquote> <table> <tbody> <tr> <td><strong>Paper:</strong> Liu et al., <em>Cell</em> (2025)</td> <td><a href="https://doi.org/10.1016/j.cell.2025.06.031">Read the paper →</a></td> </tr> </tbody> </table> <hr/> <h3 id="references">References</h3> <ul> <li>Kelsey G, Stegle O, Reik W. Single-cell epigenomics: Recording the past and predicting the future. <em>Science.</em> 2017;358(6359):69-75.</li> <li>Clark SJ, Lee HJ, Smallwood SA, Kelsey G, Reik W. Single-cell epigenomics: powerful new methods for understanding gene regulation and cell identity. <em>Genome Biol.</em> 2016;17:72.</li> <li>Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. <em>Curr Alzheimer Res.</em> 2012;9(6):628-645.</li> <li>Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. <em>Nat Methods.</em> 2013;10(12):1213-1218.</li> <li>Lieberman-Aiden E, van Berkum NL, Williams L, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. <em>Science.</em> 2009;326(5950):289-293.</li> <li>Dixon JR, Selvaraj S, Yue F, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. <em>Nature.</em> 2012;485(7398):376-380.</li> <li>Arenaza-Urquijo EM, Vemuri P. Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies. <em>Neurology.</em> 2018;90(15):695-703.</li> <li>Mathys H, Boix CA, Akay LA, et al. Single-cell multiregion dissection of Alzheimer’s disease. <em>Nature.</em> 2024;632:858-868.</li> <li>Korsunsky I, Millard N, Fan J, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. <em>Nat Methods.</em> 2019;16(12):1289-1296.</li> </ul>]]></content><author><name></name></author><category term="research-highlights"/><category term="epigenomics"/><category term="alzheimers"/><category term="single-cell"/><category term="chromatin"/><summary type="html"><![CDATA[How single-cell epigenomics reveals that Alzheimer's is fundamentally about regulatory collapse, not just protein aggregates]]></summary></entry></feed>